Search research articles
Contact Us
Filters
Showing results (51-60 of 128) with videos related to
Page
of 13
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
February 1, 1991
The severity of diabetes is a major determinant of myocardial damage in the rat
E W Thompson, J C Baker, S A Kamoss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity
P J Coopman, M T Do, E W Thompson, et al.
Placenta
|
July 28, 2010
Cadherins in the human placenta--epithelial-mesenchymal transition (EMT) and placental development
M I Kokkinos, P Murthi, R Wafai, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
July 27, 1999
Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer
J A Sharp, V Sung, J Slavin, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1992
The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs
F Leonessa, V Boulay, A Wright, et al.
Breast Cancer Research and Treatment
|
January 1, 1994
Sphingosine-1-phosphate, a novel second messenger involved in cell growth regulation and signal transduction, affects growth and invasiveness of human breast cancer cells
S Spiegel, A Olivera, H Zhang, et al.
Journal of Cellular Physiology
|
August 12, 1998
Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins
V Sung, J T Stubbs, L Fisher, et al.
Clinical & Experimental Metastasis
|
May 19, 2016
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells
A Tachtsidis, L M McInnes, N Jacobsen, et al.
Breast Cancer Research and Treatment
|
January 1, 1994
Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin]
A Staebler, C Sommers, S C Mueller, et al.
Biochemistry
|
January 12, 1988
Asymmetry of lysophosphatidylcholine/cholesterol vesicles is sensitive to cholesterol modulation
V V Kumar, W H Anderson, E W Thompson, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 128) with videos related to
Sort By:
Page
of 13
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
February 1, 1991
The severity of diabetes is a major determinant of myocardial damage in the rat
E W Thompson, J C Baker, S A Kamoss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity
P J Coopman, M T Do, E W Thompson, et al.
Placenta
|
July 28, 2010
Cadherins in the human placenta--epithelial-mesenchymal transition (EMT) and placental development
M I Kokkinos, P Murthi, R Wafai, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
July 27, 1999
Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer
J A Sharp, V Sung, J Slavin, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1992
The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs
F Leonessa, V Boulay, A Wright, et al.
Breast Cancer Research and Treatment
|
January 1, 1994
Sphingosine-1-phosphate, a novel second messenger involved in cell growth regulation and signal transduction, affects growth and invasiveness of human breast cancer cells
S Spiegel, A Olivera, H Zhang, et al.
Journal of Cellular Physiology
|
August 12, 1998
Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins
V Sung, J T Stubbs, L Fisher, et al.
Clinical & Experimental Metastasis
|
May 19, 2016
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells
A Tachtsidis, L M McInnes, N Jacobsen, et al.
Breast Cancer Research and Treatment
|
January 1, 1994
Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin]
A Staebler, C Sommers, S C Mueller, et al.
Biochemistry
|
January 12, 1988
Asymmetry of lysophosphatidylcholine/cholesterol vesicles is sensitive to cholesterol modulation
V V Kumar, W H Anderson, E W Thompson, et al.
Page
of 13